JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M103416200 on September 4, 2001

J. Biol. Chem., Vol. 276, Issue 49, 46237-46242, December 7, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/49/46237    most recent
M103416200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Escobar-Henriques, M.
Right arrow Articles by Daignan-Fornier, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Escobar-Henriques, M.
Right arrow Articles by Daignan-Fornier, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Proteome Analysis and Morphological Studies Reveal Multiple Effects of the Immunosuppressive Drug Mycophenolic Acid Specifically Resulting from Guanylic Nucleotide Depletion*

Mafalda Escobar-Henriques, Axelle Balguerie, Chistelle Monribot, Hélian Boucherie, and Bertrand Daignan-FornierDagger

From the Institut de Biochimie et Génétique Cellulaires, CNRS Unité Mixte de Recherche 5095, 1 rue Camille Saint-Saëns, F-33077 Bordeaux Cedex, France

Mycophenolic acid (MPA), one of the most promising immunosuppressive drugs recently developed, is a potent inhibitor of IMP dehydrogenase, the first committed step toward GMP synthesis. We found that all the drug effects on yeast cells were prevented by bypassing GMP synthesis, thus confirming the high specificity of MPA. Although the primary target of MPA is clearly identified, we aimed to further understand how GTP depletion leads to growth arrest and developed a new approach based on proteome analysis combined with overexpression studies. Essential proteins down-expressed in the presence of MPA were identified by protein two-dimensional gel analysis and subsequently overexpressed in yeast. Two such proteins, Cdc37p and Sup45p, when overexpressed allowed partial relief of MPA toxicity, strongly suggesting that their lower amount after MPA treatment significantly contributed to the MPA effect. These conserved proteins involved in cell cycle progression and translation are therefore important secondary targets for MPA. Our data establish that MPA effects occur through inhibition of a unique primary target resulting in guanine nucleotides depletion, thereby affecting multiple cellular processes.


* This work was supported by a fellowship from Fundação para a Ciência e Tecnologia (to M. E.-H.) and by Research Grant 5259 from ARC, and research grant from Conseil Régional d'Aquitaine and CNRS-Unité Mixte de Recherche 5095.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 33-5-56-99-90-55; Fax: 33-5-56-99-90-59; E-mail: B.Daignan-Fornier@ibgc.u-bordeaux2.fr.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
GeneticsHome page
A. Breton, B. Pinson, F. Coulpier, M.-F. Giraud, A. Dautant, and B. Daignan-Fornier
Lethal Accumulation of Guanylic Nucleotides in Saccharomyces cerevisiae HPT1-Deregulated Mutants
Genetics, February 1, 2008; 178(2): 815 - 824.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. C. McPhillips, J. W. Hyle, and D. Reines
Detection of the mycophenolate-inhibited form of IMP dehydrogenase in vivo
PNAS, August 17, 2004; 101(33): 12171 - 12176.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Escobar-Henriques, B. Daignan-Fornier, and M. A. Collart
The Critical cis-Acting Element Required for IMD2 Feedback Regulation by GDP Is a TATA Box Located 202 Nucleotides Upstream of the Transcription Start Site
Mol. Cell. Biol., September 1, 2003; 23(17): 6267 - 6278.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Hyle, R. J. Shaw, and D. Reines
Functional Distinctions between IMP Dehydrogenase Genes in Providing Mycophenolate Resistance and Guanine Prototrophy to Yeast
J. Biol. Chem., August 1, 2003; 278(31): 28470 - 28478.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Desmoucelles, B. Pinson, C. Saint-Marc, and B. Daignan-Fornier
Screening the Yeast "Disruptome" for Mutants Affecting Resistance to the Immunosuppressive Drug, Mycophenolic Acid
J. Biol. Chem., July 19, 2002; 277(30): 27036 - 27044.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.